mayo 20 2020

Mayer Brown advised SERB Group on the acquisition of the Veriton Pharma Group

Share

Paris – Mayer Brown advised SERB Specialty Pharmaceuticals (« SERB »), independent pharmaceutical company in connection with the acquisition of the Veriton Pharma Limited Group, a British pharmaceutical group, from its founder-manager and other members of the management team. 

Mayer Brown advised SERB on the structuring of the acquisition with a team composed of Laurent Borey, Olivier Parawan (partners) and Sarah Rahmoun (associate) in Paris and Matthew Mortimer (partner) and Matthew O'Brien (associate) in London.


Servicios e Industrias Relacionadas

Servicios

Industrias

Stay Up To Date With Our Insights

See how we use a multidisciplinary, integrated approach to meet our clients' needs.
Subscribe